{"id":"W2109240520","doi":"10.1200/jco.2009.22.9427","title":"Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Queen's University","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Placebo; Clinical trial; Lung cancer; Randomized controlled trial; Oncology; Internal medicine; Clinical endpoint; Double blind; Cancer; Chemotherapy; Cisplatin; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02310628,0.0003049809,0.006421109,0.0002481029,0.00004498444,0.0000173778,0.0001663932,0.0004720137,0.00009549483],"category_scores_gemma":[0.004644452,0.0001624394,0.0007209067,0.0002950492,0.0002770625,0.0001538523,0.00003144836,0.001169464,9.837158e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001940811,"about_ca_system_score_gemma":0.003427204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002457705,"about_ca_topic_score_gemma":0.00131809,"domain_scores_codex":[0.988547,0.003137208,0.007060495,0.000419545,0.0005105372,0.0003252112],"domain_scores_gemma":[0.9847415,0.009475647,0.004628488,0.0002792859,0.000414468,0.0004606261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8863081,0.009931212,0.03606935,0.0000408624,0.001375741,0.0005214801,0.0006799328,0.00005914241,0.00002514804,0.00001318748,0.0002038827,0.06477199],"study_design_scores_gemma":[0.8935656,0.06698141,0.03138524,0.00027497,0.005985787,0.00005410026,0.0008545357,0.0001489636,0.000009559163,0.00004465453,0.0005429805,0.0001521894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877349,0.001332626,0.0001560284,0.001947819,0.001347704,0.006096399,0.000008835885,0.00000887192,0.001366812],"genre_scores_gemma":[0.9918787,0.001854395,0.003676484,0.000676999,0.001253742,0.000119619,0.000004079516,0.00002838741,0.0005075465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06461981,"threshold_uncertainty_score":0.8008223,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2009292261068014,"score_gpt":0.563303123281749,"score_spread":0.3623738971749476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}